 NEW YORK, Nov. 10, 2020 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Axovant Gene Therapies Ltd. Axovant or the Company NASDAQ: AXGT. Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 7980... 